Showing results (821-830 of 1,427) with videos related to
Sort By:
Pageof 143
Case Reports in Gastrointestinal Medicine|June 14, 2021
A Patient with Eosinophilic Esophagitis and Herpes Simplex Esophagitis: A Case Report and Literature ReviewHemnishil K Marella, Jiten P Kothadia, Nasir Saleem, et al.Surgical Endoscopy|December 9, 2016
Endoscopic suture fixation is associated with reduced migration of esophageal fully covered self-expandable metal stents (FCSEMS)Andrew Wright, Andrew Chang, Aarti Oza Bedi, et al.Hepato-Gastroenterology|August 12, 2010
Presence of esophageal varices is a risk factor for non-hemorrhagic death of hepatocellular carcinoma patients treated with radiofrequency ablationKeisuke Ario, Toshihiko Mizuta, Yuichiro Eguchi, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|March 11, 2024
Long term clinical follow up of four patients with Wolfram syndrome and urodynamic abnormalitiesNimisha S Dange, Nikhil Shah, Chirantap Oza, et al.Scientific Reports|November 25, 2025
Numerical modeling and performance optimization of all inorganic Pb free novel NaSnCl<sub>3</sub> based perovskite solar cells via SCAPS-1D frameworkMuhammad Irsyad Abdullah, Virang Oza, Ravneet Kaur, et al.Journal of Translational Medicine|April 3, 2016
A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignanciesGlenwood D Goss, Derek J Jonker, Scott A Laurie, et al.AIMS Public Health|October 24, 2017
Breast cancer survivors' beliefs and preferences regarding technology-supported sedentary behavior reduction interventionsGillian R Lloyd, Sonal Oza, Sarah Kozey-Keadle, et al.British Journal of Cancer|March 1, 1992
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 yearsA M Oza, T S Ganesan, M Dorreen, et al.Cold Spring Harbor Molecular Case Studies|December 15, 2019
Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a <i>KRAS</i>-mutated low-grade serous ovarian cancer patientIlaria Colombo, Swati Garg, Arnavaz Danesh, et al.Gynecologic Oncology|April 22, 2015
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II ConsortiaH Hirte, S Lheureux, G F Fleming, et al.Pageof 143